Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 412.2% in January

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 447,700 shares, an increase of 412.2% from the December 31st total of 87,400 shares. Based on an average daily volume of 2,936,800 shares, the short-interest ratio is presently 0.2 days.

Bayer Aktiengesellschaft Price Performance

Shares of BAYRY stock traded up $0.05 during mid-day trading on Thursday, hitting $5.71. 804,560 shares of the stock were exchanged, compared to its average volume of 1,288,361. The company has a market cap of $22.44 billion, a PE ratio of -21.96 and a beta of 1.02. Bayer Aktiengesellschaft has a 52-week low of $4.79 and a 52-week high of $8.58. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19. The firm has a fifty day moving average of $5.15 and a 200 day moving average of $6.55.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.10). The business had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. Research analysts anticipate that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.